TWI606832B - 方法及組成物 - Google Patents

方法及組成物 Download PDF

Info

Publication number
TWI606832B
TWI606832B TW100140231A TW100140231A TWI606832B TW I606832 B TWI606832 B TW I606832B TW 100140231 A TW100140231 A TW 100140231A TW 100140231 A TW100140231 A TW 100140231A TW I606832 B TWI606832 B TW I606832B
Authority
TW
Taiwan
Prior art keywords
peg
mannitol
crc
solid
pharmaceutical product
Prior art date
Application number
TW100140231A
Other languages
English (en)
Chinese (zh)
Other versions
TW201304785A (zh
Inventor
彼得 史坦
伊恩 寇克斯
山姆爾 史密斯
賴頓 瓊斯
傑克 普拉瑟
菲瑞斯 寇瑞妮 迪
瑞秋 查爾頓
Original Assignee
諾金私人有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 諾金私人有限公司 filed Critical 諾金私人有限公司
Publication of TW201304785A publication Critical patent/TW201304785A/zh
Application granted granted Critical
Publication of TWI606832B publication Critical patent/TWI606832B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
TW100140231A 2010-11-04 2011-11-04 方法及組成物 TWI606832B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
US41212810P 2010-11-10 2010-11-10

Publications (2)

Publication Number Publication Date
TW201304785A TW201304785A (zh) 2013-02-01
TWI606832B true TWI606832B (zh) 2017-12-01

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100140231A TWI606832B (zh) 2010-11-04 2011-11-04 方法及組成物

Country Status (22)

Country Link
US (2) US20130216493A1 (enExample)
EP (1) EP2635289B1 (enExample)
JP (1) JP5917537B2 (enExample)
KR (1) KR20130109171A (enExample)
CN (1) CN103313719A (enExample)
AR (1) AR083770A1 (enExample)
AU (1) AU2011324996B2 (enExample)
BE (1) BE1019494A3 (enExample)
BR (1) BR112013011012A2 (enExample)
CA (1) CA2816839A1 (enExample)
EA (1) EA201300540A1 (enExample)
ES (1) ES2401269B1 (enExample)
GB (1) GB201018650D0 (enExample)
MX (1) MX349690B (enExample)
MY (1) MY163067A (enExample)
NL (1) NL2007715C2 (enExample)
NZ (1) NZ611145A (enExample)
SG (1) SG189533A1 (enExample)
TW (1) TWI606832B (enExample)
UA (1) UA107998C2 (enExample)
WO (1) WO2012059725A1 (enExample)
ZA (1) ZA201304052B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
BR112015005270B1 (pt) 2012-09-11 2022-11-01 Norgine Bv Composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
WO2020180581A1 (en) 2019-03-05 2020-09-10 Dow Global Technologies Llc Inducing caspase activity
US12350288B2 (en) 2019-03-05 2025-07-08 Dow Global Technologies Llc Inducing caspase activity
EP3934661B1 (en) * 2019-03-05 2025-04-02 Dow Global Technologies LLC Inducing caspase activity for treating colorectal cancer with polymers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110051659A1 (en) * 2009-08-28 2011-03-03 Telefonaktiebolaget Lm Ericsson (Publ) Network prefix selection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110051659A1 (en) * 2009-08-28 2011-03-03 Telefonaktiebolaget Lm Ericsson (Publ) Network prefix selection

Also Published As

Publication number Publication date
WO2012059725A8 (en) 2013-05-30
WO2012059725A1 (en) 2012-05-10
CN103313719A (zh) 2013-09-18
MY163067A (en) 2017-08-15
MX2013004963A (es) 2013-08-27
EA201300540A1 (ru) 2013-09-30
BE1019494A3 (fr) 2012-07-03
AU2011324996A1 (en) 2013-05-02
KR20130109171A (ko) 2013-10-07
AU2011324996B2 (en) 2015-10-08
ZA201304052B (en) 2014-02-26
JP5917537B2 (ja) 2016-05-18
UA107998C2 (uk) 2015-03-10
NZ611145A (en) 2015-07-31
NL2007715A (en) 2012-05-07
US20160228467A1 (en) 2016-08-11
CA2816839A1 (en) 2012-05-10
EP2635289A1 (en) 2013-09-11
SG189533A1 (en) 2013-05-31
NL2007715C2 (en) 2012-10-16
MX349690B (es) 2017-08-09
ES2401269B1 (es) 2014-02-19
GB201018650D0 (en) 2010-12-22
AR083770A1 (es) 2013-03-20
BR112013011012A2 (pt) 2016-08-23
EP2635289B1 (en) 2020-03-11
US20130216493A1 (en) 2013-08-22
JP2013544809A (ja) 2013-12-19
TW201304785A (zh) 2013-02-01
ES2401269A1 (es) 2013-04-18

Similar Documents

Publication Publication Date Title
US9089528B2 (en) Liquid compositions of calcium acetate
US20160228467A1 (en) Peg or peg block copolymer for treating colorectal cancer
Dalodom et al. Influence of oral moisturizing jelly as a saliva substitute for the relief of xerostomia in elderly patients with hypertension and diabetes mellitus
JP5872573B2 (ja) ポリエチレングリコール含有製剤
Shahidi et al. An epidemiological survey on kidney stones and related risk factors in the Iranian community
US6576665B2 (en) Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
JP2013540726A (ja) 便秘薬
IL225891A (en) Peg or block peg copolymers for the treatment of colorectal cancer
Patel Development of Novel Sustained Release Formulations for Older Adults With Swallowing Difficulties
Kingon Non-prescription medications: Considerations for the dental practitioner

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees